July 2 (Reuters) - Cartesian Therapeutics (RNAC.O), opens new tab said on Tuesday that its experimental therapy helped reduce symptoms of a rare, immune-related disorder, meeting the main goal in a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results